Granted Patent
B2
US 12,599,582 · App. 18/453,887 · Granted Apr 14, 2026
Pyrrole compounds
Inventors:
Sandrine Vendeville (Brussels, BE); David Bernard Smith (San Mateo, CA); Leonid Beigelman (San Mateo, CA); Vladimir Serebryany (Burlingame, CA)
Assignee:
Aligos Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
Claims (2)
1 . A compound having the structure
2 . A compound having the structure
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 1, 2023
From: SCHINAZI, RAYMOND F.; AMBLARD, FRANCK; BASSIT, LEDA
To: EMORY UNIVERSITY
Reel/Frame 064779/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 1, 2023
From: VENDEVILLE, SANDRINE; SMITH, DAVID BERNARD; BEIGELMAN, LEONID; SEREBRYANY, VLADIMIR
To: ALIGOS THERAPEUTICS, INC.
Reel/Frame 064779/0460 →
Continuity (5)
Provisional Application
62932686
· Nov 8, 2019
Provisional Application
62828919
· Apr 3, 2019
References Cited (129)
US 7732446B1
· Gwaltney et al.
· 2010
[cited by applicant]
US 20060102471A1
· Maurer et al.
· 2006
[cited by applicant]
US 20060105355A1
· Maurer
· 2006
[cited by applicant]
US 20070065877A1
· Maurer
· 2007
[cited by applicant]
US 20070191336A1
· Flynn et al.
· 2007
[cited by applicant]
US 20100234379A1
· Bahr et al.
· 2010
[cited by applicant]
US 20140256773A1
· Gandhi
· 2014
[cited by applicant]
US 20160166679A1
· Low et al.
· 2016
[cited by applicant]
US 20230056135A1
· Schinazi et al.
· 2023
[cited by applicant]
AU 2005221959
· 2005
[cited by applicant]
CL 201503370
· 2016
[cited by applicant]
CL 201600153
· 2016
[cited by applicant]
CL 201802549
· 2018
[cited by applicant]
CL 201900473
· 2019
[cited by applicant]
CL 201901976
· 2019
[cited by applicant]
CN 104672221
· 2015
[cited by applicant]
CN 105431413A
· 2016
[cited by applicant]
CN 108250122
· 2018
[cited by applicant]
CN 109153640A
· 2019
[cited by applicant]
CN 113454077A
· 2021
[cited by applicant]
GB 2398299
· 2004
[cited by applicant]
IN 2001DE00827
· 2005
[cited by applicant]
JP 2016539924
· 2016
[cited by applicant]
JP 2018150360
· 2018
[cited by applicant]
JP 2019507774
· 2019
[cited by applicant]
JP 2021519325
· 2021
[cited by applicant]
JP 2022508642
· 2022
[cited by applicant]
JP 2022521081
· 2022
[cited by applicant]
KR 2017013629
· 2017
[cited by applicant]
KR 2017013630
· 2017
[cited by applicant]
KR 1020180119669
· 2018
[cited by applicant]
TW 202045499A
· 2020
[cited by applicant]
UZ 5735C
· 2019
[cited by applicant]
WO WO8705926
· 1987
[cited by applicant]
WO WO2002006278
· 2002
[cited by applicant]
WO WO2002085908
· 2002
[cited by applicant]
WO WO2003013509
· 2003
[cited by applicant]
WO WO2004058164
· 2004
[cited by applicant]
WO WO2005087762
· 2005
[cited by applicant]
WO WO2006092059
· 2006
[cited by applicant]
WO WO2008033562
· 2008
[cited by applicant]
WO WO2008149382
· 2008
[cited by applicant]
WO WO2008155022
· 2008
[cited by applicant]
WO WO2010102238
· 2010
[cited by applicant]
WO WO2011050316
· 2011
[cited by applicant]
WO WO2011143466
· 2011
[cited by applicant]
WO WO2011157653
· 2011
[cited by applicant]
WO WO2012036573
· 2012
[cited by applicant]
WO WO2012047525
· 2012
[cited by applicant]
WO WO2012078902
· 2012
[cited by applicant]
WO WO2012087976
· 2012
[cited by applicant]
WO WO2012154880
· 2012
[cited by applicant]
WO WO2012154888
· 2012
[cited by applicant]
WO WO2012154967
· 2012
[cited by applicant]
WO WO2013006394
· 2013
[cited by applicant]
WO WO2013109991
· 2013
[cited by applicant]
WO WO2014047328
· 2014
[cited by applicant]
WO WO2014184350
· 2014
[cited by applicant]
WO WO2015011281
· 2015
[cited by applicant]
WO WO2015059212
· 2015
[cited by applicant]
WO WO2015134539
· 2015
[cited by applicant]
WO WO2015189331
· 2015
[cited by applicant]
WO WO2017081615
· 2017
[cited by applicant]
WO WO2017156255
· 2017
[cited by applicant]
WO WO2018039531
· 2018
[cited by applicant]
WO WO2018121689
· 2018
[cited by applicant]
WO WO2020072955
· 2020
[cited by applicant]
WO WO2020169784
· 2020
[cited by applicant]
WO WO2020205934
· 2020
[cited by applicant]
WO WO2021093172
· 2021
[cited by applicant]
WO WO2022143610
· 2022
[cited by applicant]
Office Action dated Mar. 25, 2024 for JP Application No. 2021-559054, filed Apr. 1, 2020.
[cited by applicant]
Rejection Decision dated Apr. 24, 2024, for Chinese Application No. 202080028131.4, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Aug. 27, 2024 for JP Application No. 2021-559054, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Jul. 16, 2024 for MX Application No. MX/a/2021/012105, filed Apr. 1, 2020.
[cited by applicant]
Office Action mailed Jun. 13, 2024 for UA Application No. 2021 05907, filed Apr. 1, 2020.
[cited by applicant]
Office Action mailed Jun. 12, 2024 for UZ Application No. IAP 2021 0514, filed Apr. 1, 2020.
[cited by applicant]
Examination and Search Reports dated Nov. 15, 2024 for United Arab Emirates Application No. P6001788/2021, filed Nov. 16, 2021.
[cited by applicant]
Examination Report dated Jan. 14, 2025 for Australian Patent Application No. 2020253444, filed Apr. 1, 2020.
[cited by applicant]
Search Report and Opinion dated Feb. 25, 2025 for Brazilian Patent Application No. BR112021019817-2, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Apr. 11, 2025, for Colombian Application No. NC2021/0014210, filed Apr. 1, 2020.
[cited by applicant]
Communication dated Apr. 24, 2025 for EP Application No. 20784496.0, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Apr. 7, 2025 for KR Application No. 10-2021-7035886, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Sep. 24, 2024 for MX Application No. MX/a/2021/012105, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Feb. 7, 2025 for MX Application No. MX/a/2021/012105, filed Apr. 1, 2020.
[cited by applicant]
Examination Report dated Feb. 24, 2025 for PH Application No. 1-2021-552513, filed Apr. 1, 2020.
[cited by applicant]
Search Report dated Aug. 28, 2023 for ARIPO Application No. AP/P/2021/013514, filed Apr. 1, 2020.
[cited by applicant]
Examiner's Report and Search Report dated Nov. 14, 2023 for CL Application No. 202102575, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Dec. 14, 2023, for Chinese Application No. 202080028131.4, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Mar. 18, 2024 for Israeli Application No. 286902, filed Apr. 1, 2020.
[cited by applicant]
Written Opinion dated Feb. 29. 2024 for SG Application No. 11202110718P, filed Apr. 1, 2020.
[cited by applicant]
Office Action and Search Report completed Nov. 1, 2023 for TW Application No. 109111398, filed Apr. 1, 2020.
[cited by applicant]
Communication dated Oct. 25, 2023 for EP Application No. 20784496.0, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Nov. 19, 2023 for Georgian Application No. 15762/1, filed Apr. 1, 2020.
[cited by applicant]
Second Examination Report dated Nov. 7, 2022 for Indian Patent Application No. 202117049271, filed Apr. 1, 2020.
[cited by applicant]
“IUPAC-IUB Commission on Biochemical Nomenclature Abbreviated Nomenclature of Synthetic Polypeptides (Polymerized Amino Acids) Revised Recommendations (1971)”
[cited by applicant]
Liang, “Hepatitis B: The Virus and Disease” Hepatology (2009) 49(S5):S13-S21.
[cited by applicant]
International Search Report and Written Opinion mailed Jun. 24, 2020 for PCT Application No. PCT/US2020/026116, filed Apr. 1, 2020.
[cited by applicant]
Second Written Opinion mailed Feb. 26, 2021 for PCT Application No. PCT/US2020/026116, filed Apr. 1, 2020.
[cited by applicant]
International Preliminary Report on Patentability mailed Jul. 28, 2021 for PCT Application No. PCT/US2020/026116, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Apr. 26, 2021 for U.S. Appl. No. 16/837,515, filed Apr. 1, 2020.
[cited by applicant]
Examination Report dated Mar. 10, 2022 for Indian Patent Application No. 202117049271, filed Apr. 1, 2020.
[cited by applicant]
Opposition dated Apr. 19, 2022, for Colombian Application No. NC2021/0014210, filed Apr. 1, 2020.
[cited by applicant]
Extended European Search Report dated Oct. 21, 2022 for EP Application No. 20784496.0, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Apr. 17, 2023 for Eurasian Application No. 202192569, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Nov. 10, 2022 for Georgian Application No. 15762/1, filed Apr. 1, 2020.
[cited by applicant]
Examiner's Report and Search Report dated May 16, 2023 for CL Application No. 202102575, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Jun. 1, 2023, for Chinese Application No. 202080028131.4, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Feb. 6, 2023 for U.S. Appl. No. 17/455,178, filed Nov. 16, 2021.
[cited by applicant]
Office Action dated Aug. 24, 2023 for Indonesian Application No. P00202108226, filed Apr. 1, 2020.
[cited by applicant]
Examination Report dated May 14, 2025 for CA Application No. 3,134,635, filed Apr. 1, 2020.
[cited by applicant]
Office Action dated Aug. 7, 2025 for Indonesian Application No. P00202108226, filed Apr. 1, 2020.
[cited by applicant]
First Examination Report dated Dec. 30, 2025 for Indian Patent Application No. 202218052838, filed Apr. 1, 2020.
[cited by applicant]
Examination Report dated Sep. 29, 2025 for MY Application No. PI2021005800, filed Apr. 1, 2020.
[cited by applicant]
Technical Report issued Oct. 31, 2025 for PE Application No. 1658-2021, filed Apr. 1, 2020.
[cited by applicant]
Examination Report dated Aug. 12, 2025 for SG Application No. 11202110718P, filed Apr. 1, 2020.
[cited by applicant]
Office Action mailed Jul. 3, 2025 for UZ Application No. IAP 2021 0514, filed Apr. 1, 2020.
[cited by applicant]